An observational study in Long COVID, Long Covid19 and Post-COVID-19 Syndrome, sponsored by Metamorphosis LTD. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2023-04-13.
Sponsored by Metamorphosis LTD · Observational
An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long COVID-19.
We evaluated the treatment results of 41 patients (18 male and 23 female) aged between 18 and 89, who received Stellate Ganglion Block (SGB) with Ultrasound guidance for Long COVID-19 Syndrome. The patients were from the United States and received treatment at our Colorado clinics during the period of September to December 2022.Those who responded to our post-procedure follow-up calls were included in the study population.
604 studies on the registry are indexed under Post-Acute COVID-19 Syndrome; 201 are open to participants now.
This study's enrollment of 41 is below the median of 150 across 173 observational studies indexed under Post-Acute COVID-19 Syndrome.
Browse Post-Acute COVID-19 Syndrome studies →This is the only study on the registry with Metamorphosis LTD as lead sponsor.
Counted across the registry records on this site, refreshed daily.
The study included 18 male and 23 females with an age range between 18 and 89 who underwent stellate ganglion block (SGB) for long COVID-19 Syndrome.
Inclusion Criteria: People who scheduled themselves for a SGB in our clinics in Colorado.
-
Exclusion Criteria:
Stellate Ganglion Block
-
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients who received ultrasound guided Stellate Ganglion block for symptoms of Long COVID in our Colorado clinics.
Procedure: Stellate Ganglion Block
Ultrasound guided block of the Stellate Ganglion with local anesthetics.
Also known as: SGB
Symptom Response
Evaluation of the symptoms response to the Stellate Ganglion Block
Time frame: 3 months
Plan to share: Yes — Plan to share data file
Supporting information: Statistical analysis plan, Clinical study report
Time frame: Within a month
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Post-Acute COVID-19 Syndrome →